InsiderFlow

Peter Greenleaf

AUPH

Peter Greenleaf serves as director at Aurinia Pharmaceuticals Inc. (AUPH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$54.9K

Total Sells

7 trades

$7.25M

Net Position

Net Seller

$7.19M

Companies Traded

2

PTHS, AUPH

Active Period

May 2021 – Apr 2026

8 total trades

Most Recent

Sell PTHS

Apr 6, 2026 · $16.7K

Peter Greenleaf's Insider Trading at Aurinia Pharmaceuticals Inc. (AUPH)

Buys

1 · $54.9K

Sells

6 · $7.23M

Total Shares Bought

5,125

Total Shares Sold

742,679

AUPH Price Chart
Loading chart...
DateTypeValue
Feb 20, 2026 Sell$1.44M
Jan 2, 2026 Sell$1.81M
Feb 28, 2025 Sell$2.87M
Mar 6, 2024 Sell$711.1K
Mar 2, 2023 Sell$292.8K
Mar 2, 2022 Sell$108.9K
May 11, 2021 Buy$54.9K

Peter Greenleaf's Insider Trading at Pelthos Therapeutics Inc. (PTHS)

Buys

0 · $0.00

Sells

1 · $16.7K

Total Shares Bought

0

Total Shares Sold

797

PTHS Price Chart
Loading chart...
DateTypeValue
Apr 6, 2026 Sell$16.7K

Related Insiders

Matthew Pauls

director

PTHSSell · Apr 6, 2026

Richard Malamut

director

PTHSSell · Apr 6, 2026

Ezra M Friedberg

Director

PTHSSell · Apr 6, 2026

Matthew Maxwell Donley

Chief Operating Officer

AUPHSell · Feb 20, 2026

Stephen P. Robertson

EVP, General Counsel

AUPHSell · Feb 20, 2026

Joseph M Miller

Chief Financial Officer

AUPHSell · Feb 20, 2026

Greg Keenan

SVP, Chief Medical Officer

AUPHSell · Feb 2, 2026

Jeffrey Allen Bailey

Director

AUPHSell · Nov 21, 2025

Explore More Insider Trading Data

AUPH Insider Trading Activity

View all insider trades at Aurinia Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity